Research ArticleArticle
Open Access
Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease, Jacqueline B. Palmer, Mei Liu, Arthur Kavanaugh, Renganayaki Pandurengan, Christopher T. Ritchlin, Chitra Karki and Jeffrey D. Greenberg
The Journal of Rheumatology July 2018, jrheum.171094; DOI: https://doi.org/10.3899/jrheum.171094
Philip J. Mease
From the Swedish Medical Center and University of Washington, Seattle, Washington; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; Corrona LLC, Waltham, Massachusetts; University of California San Diego, La Jolla, California; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester; New York University School of Medicine, New York, New York, USA. In the last 2 years, AbbVie, Amgen, BMS, Crescendo, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB have supported Corrona LLC, through contracted subscriptions. The study design and conduct were the result of a collaborative effort between Corrona and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data, review, and approval of the manuscript. J.B. Palmer is an employee of Novartis. M. Liu is an employee of Corrona LLC. R. Pandurengan and C. Karki were employees of Corrona LLC, at the time of this study. J.D. Greenberg is an employee and shareholder of Corrona LLC. P.J. Mease, MD, Swedish Medical Center and University of Washington; J.B. Palmer, PharmD, Novartis Pharmaceuticals Corp.; M. Liu, PhD, Corrona LLC; C. Karki, MPH, Corrona LLC; A. Kavanaugh, MD, University of California San Diego; R. Pandurengan, PhD, Corrona LLC; C.T. Ritchlin, MD, MPH, Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center; J.D. Greenberg, MD, MPH, Corrona LLC, and New York University School of Medicine. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 28, 2018.
Jacqueline B. Palmer
From the Swedish Medical Center and University of Washington, Seattle, Washington; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; Corrona LLC, Waltham, Massachusetts; University of California San Diego, La Jolla, California; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester; New York University School of Medicine, New York, New York, USA. In the last 2 years, AbbVie, Amgen, BMS, Crescendo, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB have supported Corrona LLC, through contracted subscriptions. The study design and conduct were the result of a collaborative effort between Corrona and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data, review, and approval of the manuscript. J.B. Palmer is an employee of Novartis. M. Liu is an employee of Corrona LLC. R. Pandurengan and C. Karki were employees of Corrona LLC, at the time of this study. J.D. Greenberg is an employee and shareholder of Corrona LLC. P.J. Mease, MD, Swedish Medical Center and University of Washington; J.B. Palmer, PharmD, Novartis Pharmaceuticals Corp.; M. Liu, PhD, Corrona LLC; C. Karki, MPH, Corrona LLC; A. Kavanaugh, MD, University of California San Diego; R. Pandurengan, PhD, Corrona LLC; C.T. Ritchlin, MD, MPH, Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center; J.D. Greenberg, MD, MPH, Corrona LLC, and New York University School of Medicine. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 28, 2018.
Mei Liu
From the Swedish Medical Center and University of Washington, Seattle, Washington; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; Corrona LLC, Waltham, Massachusetts; University of California San Diego, La Jolla, California; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester; New York University School of Medicine, New York, New York, USA. In the last 2 years, AbbVie, Amgen, BMS, Crescendo, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB have supported Corrona LLC, through contracted subscriptions. The study design and conduct were the result of a collaborative effort between Corrona and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data, review, and approval of the manuscript. J.B. Palmer is an employee of Novartis. M. Liu is an employee of Corrona LLC. R. Pandurengan and C. Karki were employees of Corrona LLC, at the time of this study. J.D. Greenberg is an employee and shareholder of Corrona LLC. P.J. Mease, MD, Swedish Medical Center and University of Washington; J.B. Palmer, PharmD, Novartis Pharmaceuticals Corp.; M. Liu, PhD, Corrona LLC; C. Karki, MPH, Corrona LLC; A. Kavanaugh, MD, University of California San Diego; R. Pandurengan, PhD, Corrona LLC; C.T. Ritchlin, MD, MPH, Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center; J.D. Greenberg, MD, MPH, Corrona LLC, and New York University School of Medicine. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 28, 2018.
Arthur Kavanaugh
From the Swedish Medical Center and University of Washington, Seattle, Washington; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; Corrona LLC, Waltham, Massachusetts; University of California San Diego, La Jolla, California; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester; New York University School of Medicine, New York, New York, USA. In the last 2 years, AbbVie, Amgen, BMS, Crescendo, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB have supported Corrona LLC, through contracted subscriptions. The study design and conduct were the result of a collaborative effort between Corrona and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data, review, and approval of the manuscript. J.B. Palmer is an employee of Novartis. M. Liu is an employee of Corrona LLC. R. Pandurengan and C. Karki were employees of Corrona LLC, at the time of this study. J.D. Greenberg is an employee and shareholder of Corrona LLC. P.J. Mease, MD, Swedish Medical Center and University of Washington; J.B. Palmer, PharmD, Novartis Pharmaceuticals Corp.; M. Liu, PhD, Corrona LLC; C. Karki, MPH, Corrona LLC; A. Kavanaugh, MD, University of California San Diego; R. Pandurengan, PhD, Corrona LLC; C.T. Ritchlin, MD, MPH, Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center; J.D. Greenberg, MD, MPH, Corrona LLC, and New York University School of Medicine. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 28, 2018.
Renganayaki Pandurengan
From the Swedish Medical Center and University of Washington, Seattle, Washington; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; Corrona LLC, Waltham, Massachusetts; University of California San Diego, La Jolla, California; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester; New York University School of Medicine, New York, New York, USA. In the last 2 years, AbbVie, Amgen, BMS, Crescendo, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB have supported Corrona LLC, through contracted subscriptions. The study design and conduct were the result of a collaborative effort between Corrona and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data, review, and approval of the manuscript. J.B. Palmer is an employee of Novartis. M. Liu is an employee of Corrona LLC. R. Pandurengan and C. Karki were employees of Corrona LLC, at the time of this study. J.D. Greenberg is an employee and shareholder of Corrona LLC. P.J. Mease, MD, Swedish Medical Center and University of Washington; J.B. Palmer, PharmD, Novartis Pharmaceuticals Corp.; M. Liu, PhD, Corrona LLC; C. Karki, MPH, Corrona LLC; A. Kavanaugh, MD, University of California San Diego; R. Pandurengan, PhD, Corrona LLC; C.T. Ritchlin, MD, MPH, Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center; J.D. Greenberg, MD, MPH, Corrona LLC, and New York University School of Medicine. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 28, 2018.
Christopher T. Ritchlin
From the Swedish Medical Center and University of Washington, Seattle, Washington; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; Corrona LLC, Waltham, Massachusetts; University of California San Diego, La Jolla, California; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester; New York University School of Medicine, New York, New York, USA. In the last 2 years, AbbVie, Amgen, BMS, Crescendo, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB have supported Corrona LLC, through contracted subscriptions. The study design and conduct were the result of a collaborative effort between Corrona and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data, review, and approval of the manuscript. J.B. Palmer is an employee of Novartis. M. Liu is an employee of Corrona LLC. R. Pandurengan and C. Karki were employees of Corrona LLC, at the time of this study. J.D. Greenberg is an employee and shareholder of Corrona LLC. P.J. Mease, MD, Swedish Medical Center and University of Washington; J.B. Palmer, PharmD, Novartis Pharmaceuticals Corp.; M. Liu, PhD, Corrona LLC; C. Karki, MPH, Corrona LLC; A. Kavanaugh, MD, University of California San Diego; R. Pandurengan, PhD, Corrona LLC; C.T. Ritchlin, MD, MPH, Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center; J.D. Greenberg, MD, MPH, Corrona LLC, and New York University School of Medicine. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 28, 2018.
Chitra Karki
From the Swedish Medical Center and University of Washington, Seattle, Washington; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; Corrona LLC, Waltham, Massachusetts; University of California San Diego, La Jolla, California; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester; New York University School of Medicine, New York, New York, USA. In the last 2 years, AbbVie, Amgen, BMS, Crescendo, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB have supported Corrona LLC, through contracted subscriptions. The study design and conduct were the result of a collaborative effort between Corrona and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data, review, and approval of the manuscript. J.B. Palmer is an employee of Novartis. M. Liu is an employee of Corrona LLC. R. Pandurengan and C. Karki were employees of Corrona LLC, at the time of this study. J.D. Greenberg is an employee and shareholder of Corrona LLC. P.J. Mease, MD, Swedish Medical Center and University of Washington; J.B. Palmer, PharmD, Novartis Pharmaceuticals Corp.; M. Liu, PhD, Corrona LLC; C. Karki, MPH, Corrona LLC; A. Kavanaugh, MD, University of California San Diego; R. Pandurengan, PhD, Corrona LLC; C.T. Ritchlin, MD, MPH, Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center; J.D. Greenberg, MD, MPH, Corrona LLC, and New York University School of Medicine. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 28, 2018.
Jeffrey D. Greenberg
From the Swedish Medical Center and University of Washington, Seattle, Washington; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; Corrona LLC, Waltham, Massachusetts; University of California San Diego, La Jolla, California; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester; New York University School of Medicine, New York, New York, USA. In the last 2 years, AbbVie, Amgen, BMS, Crescendo, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB have supported Corrona LLC, through contracted subscriptions. The study design and conduct were the result of a collaborative effort between Corrona and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data, review, and approval of the manuscript. J.B. Palmer is an employee of Novartis. M. Liu is an employee of Corrona LLC. R. Pandurengan and C. Karki were employees of Corrona LLC, at the time of this study. J.D. Greenberg is an employee and shareholder of Corrona LLC. P.J. Mease, MD, Swedish Medical Center and University of Washington; J.B. Palmer, PharmD, Novartis Pharmaceuticals Corp.; M. Liu, PhD, Corrona LLC; C. Karki, MPH, Corrona LLC; A. Kavanaugh, MD, University of California San Diego; R. Pandurengan, PhD, Corrona LLC; C.T. Ritchlin, MD, MPH, Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center; J.D. Greenberg, MD, MPH, Corrona LLC, and New York University School of Medicine. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication February 28, 2018.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease, Jacqueline B. Palmer, Mei Liu, Arthur Kavanaugh, Renganayaki Pandurengan, Christopher T. Ritchlin, Chitra Karki, Jeffrey D. Greenberg
The Journal of Rheumatology Jul 2018, jrheum.171094; DOI: 10.3899/jrheum.171094
Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease, Jacqueline B. Palmer, Mei Liu, Arthur Kavanaugh, Renganayaki Pandurengan, Christopher T. Ritchlin, Chitra Karki, Jeffrey D. Greenberg
The Journal of Rheumatology Jul 2018, jrheum.171094; DOI: 10.3899/jrheum.171094